Literature DB >> 22120673

The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2.

Gitte Lauritzen1, Christian-Martin Stock, Justine Lemaire, Stine F Lund, Mie Frid Jensen, Britt Damsgaard, Katrine Seide Petersen, Maria Wiwel, Lone Rønnov-Jessen, Albrecht Schwab, Stine Falsig Pedersen.   

Abstract

We and others have shown central roles of the Na(+)/H(+) exchanger NHE1 in cell motility. The aim of this study was to determine the roles of NHE1 and of the Na(+), HCO(3)(-) cotransporter NBCn1 in motility of serum-starved MCF-7 breast cancer cells expressing constitutively active ErbB2 (ΔNErbB2). ΔNErbB2 expression elicited NBCn1 upregulation, Ser(703)-phosphorylation of NHE1, and NHE1-inhibitor (EIPA)-sensitive pericellular acidification, in conjunction with increased expression of β1 integrin and ERM proteins. Active ERM proteins and NHE1 colocalized strongly to invadopodial rosettes, the diameter of which was increased by ΔNErbB2. Adhesion and migration on collagen-I were augmented by ΔNErbB2, unaffected by the NBC inhibitor S0859, and further stimulated by EIPA in a manner potentiated by PI3K-Akt-inhibition. These findings demonstrate that NHE1 inhibition can enhance cancer cell motility, adding an important facet to the understanding of NHE1 in cancer.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120673     DOI: 10.1016/j.canlet.2011.11.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  48 in total

Review 1.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 2.  Hypoxia and cellular metabolism in tumour pathophysiology.

Authors:  Scott K Parks; Yann Cormerais; Jacques Pouysségur
Journal:  J Physiol       Date:  2017-02-19       Impact factor: 5.182

Review 3.  Ion channels and transporters in tumour cell migration and invasion.

Authors:  Albrecht Schwab; Christian Stock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

4.  Na+,HCO3- -cotransport is functionally upregulated during human breast carcinogenesis and required for the inverted pH gradient across the plasma membrane.

Authors:  Soojung Lee; Marco Mele; Pernille Vahl; Peer M Christiansen; Vibeke E D Jensen; Ebbe Boedtkjer
Journal:  Pflugers Arch       Date:  2014-05-02       Impact factor: 3.657

5.  Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺ extrusion, cell migration and survival.

Authors:  Damin Cong; Wen Zhu; Yejie Shi; Kelli B Pointer; Paul A Clark; Hongmei Shen; John S Kuo; Shaoshan Hu; Dandan Sun
Journal:  Carcinogenesis       Date:  2014-04-09       Impact factor: 4.944

6.  Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.

Authors:  Elena Pedraz-Cuesta; Jacob Fredsted; Helene H Jensen; Annika Bornebusch; Lene N Nejsum; Birthe B Kragelund; Stine F Pedersen
Journal:  Mol Endocrinol       Date:  2016-05-13

Review 7.  Cation-coupled bicarbonate transporters.

Authors:  Christian Aalkjaer; Ebbe Boedtkjer; Inyeong Choi; Soojung Lee
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

8.  Disrupting Na⁺, HCO₃⁻-cotransporter NBCn1 (Slc4a7) delays murine breast cancer development.

Authors:  S Lee; T V Axelsen; A P Andersen; P Vahl; S F Pedersen; E Boedtkjer
Journal:  Oncogene       Date:  2015-07-27       Impact factor: 9.867

Review 9.  Disrupting proton dynamics and energy metabolism for cancer therapy.

Authors:  Scott K Parks; Johanna Chiche; Jacques Pouysségur
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

Review 10.  TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration.

Authors:  N Nielsen; O Lindemann; A Schwab
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.